Back
Axsome Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Sell
40
AXSM
Axsome Therapeutics
Last Price:
86.47
Seasonality Move:
-7.27%
Buy
64
CPRX
Catalyst Pharmaceuticals
Last Price:
17.59
Seasonality Move:
14.5%
Sell
40
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $85.98. The Score for AXSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $17.37. The Score for CPRX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $85.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing slight buying pressure.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $17.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.25 | Buy |
| Relative Strength Index (14 RSI): | 62.34 | Buy |
| Chaikin Money Flow: | 79324 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.8 - 84.82) | Buy |
| Bollinger Bands (100): | (71.37 - 80.51) | Buy |
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 67.12 | Buy |
| Chaikin Money Flow: | -925890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.25 - 16.93) | Buy |
| Bollinger Bands (100): | (15.17 - 16.51) | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.83 | Buy |
| 20-day SMA: | 82.94 | Buy |
| 50-day SMA: | 78.32 | Buy |
| 200-day SMA: | 75.82 | Buy |
| 8-day EMA: | 84.83 | Buy |
| 20-day EMA: | 82.78 | Buy |
| 50-day EMA: | 79.66 | Buy |
| 200-day EMA: | 76.27 | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.13 | Buy |
| 20-day SMA: | 16.29 | Buy |
| 50-day SMA: | 16.02 | Buy |
| 200-day SMA: | 14.98 | Buy |
| 8-day EMA: | 17.09 | Buy |
| 20-day EMA: | 16.54 | Buy |
| 50-day EMA: | 16.06 | Buy |
| 200-day EMA: | 15.2 | Buy |
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.52 per share, a decrease this year of $0.56 per share, and an increase next year of $4.08 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.13 per share, and an increase next year of $0.17 per share.
Axsome Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Catalyst Pharmaceuticals Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||